|
Volume 272, Number 46, Issue of November 14, 1997
pp. 29099-29103
Influence of Protein-Glutathione Mixed Disulfide on the
Chaperone-like Function of -Crystallin*
(Received for publication, August 4, 1997, and in revised form, September 10, 1997)
Mary
Cherian
,
Jean B.
Smith
§,
Xiang-Yu
Jiang
§ and
Edathara C.
Abraham
¶
From the Department of Biochemistry and Molecular
Biology, Medical College of Georgia, Augusta, Georgia 30912-2100 and
the § Department of Chemistry, University of Nebraska,
Lincoln, Nebraska 68588-0304
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
In an earlier report we showed that incubation of
-crystallin with oxidized glutathione results in significant loss of
its chaperone-like activity. In the present study, we determined the effect of protein-glutathione mixed disulfides (PSSG), formed at
Cys-131 in bovine A-crystallin, and Cys-131 and Cys-142 in human
A-crystallin, on the function of -crystallin as a molecular chaperone. After incubation of calf and young human
L-crystallin fractions with oxidized glutathione,
levels of PSSG were determined by performic acid oxidation of the mixed
disulfides followed by reversed-phase high pressure liquid
chromatography separation of phenylisothiocyanate-derivatized
glutathione sulfonic acid. Levels of PSSG increased from 0.01 to 0.14 nmol/nmol (20 kDa) in bovine L-crystallin and from 0.022 to 0.25 nmol/nmol in human L-crystallin. The presence of
glutathione adducts at Cys-131 and Cys-142 were confirmed by mass
spectral analysis. The chaperone-like activity was determined by the
heat denaturation assay using L-crystallin as the target
protein. To examine the reversibility of the effect of mixed disulfides
on chaperone activity, studies were done before and after reduction
with the glutathione reductase system. Increased levels of PSSG
resulted in lower chaperone activities. Treatment with the glutathione
reductase system led to 80% reduction in PSSG levels with a
concomitant recovery of the chaperone activity. These results suggest
that cysteine(s) in the A-crystallin subunit play an important role
in the function of -crystallin as a molecular chaperone.
INTRODUCTION
-Crystallin is one of the major eye lens proteins, representing
about 35% of the total protein in the lens. It comprises two
homologous subunits, A and B, with a molecular mass of 20 kDa
each. Native -crystallin exists as an oligomer with a molecular mass
in the 360-800 kDa range. Historically, it was thought to be
lens-specific, playing a structural role in maintaining transparency and thus facilitating light transmission to the retina. The idea that
-crystallin is purely lens-specific, playing only a structural role
in the lens is no longer tenable. -Crystallin, especially the B
subunit, is known to be widely expressed in other tissues, such as
heart, kidney, placenta, lungs, and skeletal muscle (1-5). A-
Crystallin is found in the thymus and spleen (4, 6). B-Crystallin
accumulates in certain pathological conditions in the central nervous
system, such as in Alexander's disease, a degenerative neurological
disorder (2), multiple sclerosis (7), and Lewy body disease (8). The
natural occurrence of -crystallin in various cell types and its
increased expression in neurological diseases and other stress
conditions like heat stress (9) and hypertonic stress (10) suggest an
important functional role besides a structural role.
Ingolia and Craig discovered sequence similarities between small heat
shock proteins (hsp) of Drosophila and -crystallins (11). Based on
this sequence homology both A- and B-crystallins are considered
members of the hsp family. B-Crystallin and hsp 27 can be induced in
cell lines under stress conditions such as heat shock, oxidative
stress, and exposure to transition metals (12, 13). One of the
functions of a heat shock protein is to act as molecular chaperone,
binding to partially denatured proteins preventing further denaturation
and/or facilitating refolding of proteins to their native state.
-Crystallin has been shown to have such a chaperone-like function
and is known to form a stable complex with denatured or partially
unfolded proteins, preventing further aggregation (14-17). During
aging and cataractogenesis of the lens, both subunits of -crystallin
undergo extensive post-translational modifications such as deamidation
(18, 19), isomerization, racemization (20), oxidation (21),
intramolecular disulfide bond formation (22), mixed disulfide formation
(23, 24), and glycation (25). The ocular lens is under constant
oxidative stress. In most types of cataracts, the common factor appears to be depletion of glutathione
(GSH1), presumably through
the formation of oxidized glutathione (GSSG), which in turn forms
protein-glutathione mixed disulfides (PSSG) (23, 24, 26, 27). Human
lenses exposed to oxidative stress have elevated levels of PSSG (27), a
precursor of protein disulfides. PSSG and protein-cysteine mixed
disulfides (PSSC) are two major forms of protein-bound thiols in human
lenses (24, 27).
Horwitz first reported the molecular chaperone-like function of
-crystallin (14). The chaperone function of -crystallin has been
shown to decline with aging in human lenses (28). Therefore, determining the factors that lead to its dysfunction as a chaperone is
important in understanding the age-related changes causing opacification of the lens. The central focus of this communication is
the formation of mixed disulfide between -crystallin and oxidized glutathione, and the effect of mixed disulfides on chaperone activity of -crystallin. Preliminary studies have shown that incubation of
bovine -crystallin with GSSG leads to a significant decrease in the
chaperone-like activity (28). However, it is not certain whether
protein-glutathione mixed disulfides are the true cause of this
decrease. This investigation shows that incubation with GSSG causes
mixed disulfides to form at Cys-131 of bovine A-crystallin and at
both Cys-131 and Cys-142 of human A-crystallin. Additionally, we
show that the chaperone activity can be recovered by reducing the mixed
disulfides with glutathione reductase (GR).
EXPERIMENTAL PROCEDURES
Freshly collected calf lenses were obtained from a local
abattoir. Human lenses from the Eye Bank of the Medical College of Georgia were pooled from 12-20-year-olds. Calf and human lenses were
homogenized in 50 mM Tris, 50 mM
NaHSO3, 20 mM EDTA, pH 7.4. After
centrifugation at 10,000 × g for 1 h at 4 °C,
the supernatant water-soluble fractions were collected. About 30 mg of
the soluble protein was resolved by preparative Sephacryl S-300-HR
chromatography on a 100 × 1.5-cm column. The purity of calf and
human crystallin fractions used in this study was confirmed by
SDS-polyacrylamide gel electrophoresis (29).
In Vitro Modification of L-Crystallin
The
L-crystallin fraction from calf lenses or
12-20-year-old human lenses (5 mg/ml) in 50 mM Tris
buffer, 20 mM EDTA, pH 7.4 containing 0.02%
NaN3 was sterile filtered through 0.2 µm filters (Gelman
Sciences) and incubated for 24 h with 25 mM GSSG. After incubation, analysis of proteins by SDS-polyacrylamide gel electrophoresis did not reveal any degradation during incubation. To
reduce the PSSG formed during the GSSG incubations, half of the
incubation mixtures from both bovine and human
L-crystallins were further incubated for 90 min with 10 units/ml of GR and 2 mM NADPH. Part of the old (60-70
years) human L-crystallin (10 mg/2 ml) was also
subjected to treatment with GR and NADPH.
Determination of Protein-Glutathione Mixed Disulfides
The
procedure of Kumari et al. (30) with minor modifications was
used to determine protein-glutathione mixed disulfides. About 10 mg of
the calf or human L-crystallin were precipitated in 10%
trichloroacetic acid, washed thoroughly in 5% trichloroacetic acid,
methanol:ether, 1:1 and oxidized with performic acid, which releases
glutathione as glutathione sulfonic acid. The sulfonic acid was
derivatized by PITC. The phenylthiocarbamyl derivative was separated by
HPLC on a phenomenex reversed-phase ODS 2 Sphereclone; 3 µ poresize;
100 × 4.6-mm column. The column was equilibrated in a developer
containing 50 mM sodium acetate, 0.05% triethylamine (v/v), 0.5% acetonitrile (v/v), with pH adjusted to 6.6 with acetic acid. After applying the sample, the column was developed isocratically with the same developer. Using glutathione sulfonic acid standard, concentrations of glutathione sulfonic acid were calculated from the
recorded peak areas and expressed per nmol of 20-kDa
-crystallin.
Mass Spectrometric Analysis of Human -Crystallin Before and
After Incubation with GSSG
The molecular weights of the
-crystallins were determined using an on-line reversed-phase
microbore column (5-cm × 1.0-mm inner diameter Vydac C-4, 300 A)
attached to an electrospray ionization mass spectrometer (Micromass
Platform II Quadrupole, Manchester, UK). The sample, 20 µl of the
incubation mixture, was injected into the column at a flow rate of 50 µl/min. A post-column splitter directed 5 µl/min to the mass
spectrometer and 45 µl/min to a UV monitor and fraction collector. A
linear gradient of 35-60% acetonitrile in water, with 0.1%
trifluoroacetic acid, over 25 min separated the A- and
B-crystallins. MassLynx software was used to calculate the molecular
weights of the proteins from the multiple charged peaks of the
electrospray ionization mass spectrometry spectrum.
Molecular Chaperone Assay
Chaperone-like activity of
L-crystallin was determined by performing heat
denaturation studies according to Horwitz (14). The ability of the
unmodified or modified human or bovine -crystallin preparation to
protect calf L-crystallin (used as the target protein)
from heat-induced denaturation and aggregation was assessed as follows:
40 µg of L-crystallin fraction was added to 400 µg of L-crystallin into a 1.5-ml cuvette and made up to a
final volume of 1 ml with 50 mM phosphate buffer, pH 7.0. The cuvette was placed in a temperature-regulated cell holder attached
to a Shimadzu model UV 160 spectrophotometer. Light scattering due to
protein denaturation and aggregation was monitored (scanned) at 360 nm
absorbance over a time period of 3000 s at 55 °C or 1800 s
at 58 °C.
Other Methods
SDS-polyacrylamide gel electrophoresis was
performed according to Laemmli (29) using the Bio-Rad Mini-Protean II
system. 10 µg of the samples were loaded onto a reducing gel and run
at 200 volts. Protein concentrations were determined according to the
method of Bradford (31).
RESULTS
Levels of Protein( -Crystallin)-Glutathione Mixed
Disulfides
Glutathione mixed disulfides were determined by
reversed-phase HPLC separation of glutathione sulfonic acid after
oxidation with performic acid (Fig. 1).
The L-crystallin from calf and young human lenses,
before and after GSSG treatment, was used for these analyses; the
results are summarized in Table I. Calf L fraction contained a very low level (0.01 nmol/nmol of
20-kDa monomer) of PSSG. After GSSG treatment, the level increased
14-fold to 0.142 nmol/nmol. Treatment of young human
L-crystallin with 25 mM GSSG increased the
PSSG content to 0.25 nmol/nmol of protein. Since about one-third of
calf (or young human) -crystallin is B-crystallin (32) containing
no cysteine, the level of A-crystallin modification was
approximately 0.21 nmol/nmol in calf L-crystallin and
0.38 nmol/nmol in human L-crystallin. Subsequent
treatment with GR almost completely reduced the in vitro
formed PSSG.
Fig. 1.
Reversed-phase HPLC elution profile of
PITC-derivatized glutathione sulfonic acid released from
L-crystallin bound glutathione mixed disulfides.
L-crystallin fraction was incubated (5 mg/ml) for
24 h with or without 25 mM oxidized glutathione
(GSSG) in Tris buffer. After dialysis, GR (10 units/ml) and
NADPH (2 mM) were incubated with half of L + GSSG for a further 1.5 h. Aliquots containing 10 mg of protein
from each incubation were precipitated with trichloroacetic acid,
oxidized by performic acid, derivatized with PITC, separated by C-18
RP-HPLC column, and absorbance was monitored at 254 nm. A,
L-crystallin alone; B, L + GSSG; C, L + GSSG + GR; D,
PITC-derivatized standards; glutathione sulfonic acid and cysteic
acid.
[View Larger Version of this Image (13K GIF file)]
Results of Electrospray Ionization Mass Spectrometry of Human
A-Crystallin
Human L-crystallin (from young
lenses) was analyzed by electrospray ionization mass spectrometry
before and after incubation with GSSG. B- and A-crystallins were
first separated by on-line reversed-phase HPLC and both were analyzed
by mass spectrometry. Only A-crystallin showed a change in molecular
weight (Fig. 2) (19). The electrospray
ionization mass spectrum of A-crystallin, before incubation with
GSSG, showed peaks corresponding to A-crystallin (calculated
Mr 19,952), A-crystallin minus the C-terminal
serine (Mr 19,865), and A-crystallin with one
phosphorylation (Mr 20,032). After incubation
with GSSG, the molecular weights indicated that both cysteines were
partially modified (Fig. 2). The formation of a GSH adduct at a
cysteine increases the molecular mass by 305 Da. The mass spectrum of
the L-crystallin incubated in GSSG included additional
peaks corresponding to A plus one GSH (Mr 20,257); A minus serine plus one GSH (Mr
20,170); A plus a phosphate and one GSH (Mr
20,357); A plus two GSH adducts (Mr 20,562); A minus serine, plus two GSH adducts (Mr
20,475); and A plus a phosphate and two GSH adducts
(Mr 20,642). The largest peak in a mass spectrum
is displayed as 100% response, and all other peaks are adjusted
relative to this peak. Thus, comparison of the sizes of the various
peaks within a mass spectrum indicates relative abundance of the
proteins. However, such comparisons between two mass spectra are not
valid. The mass spectra (Fig. 2, A and B) show
that all the peaks with masses of 20,032 and below belong to
A-crystallin without GSH adducts. The remaining six major peaks are
generated entirely due to in vitro thiolation with GSSG.
There is about 50% modification of A-crystallin by mixed disulfide
formation (Fig. 2B).
Fig. 2.
Reconstructed electrospray mass spectrum of
human A-crystallin. Before (A) and after
(B) 24 h of incubation with GSSG. The major peaks
identified by matching the determined molecular masses within 2 µm of
the calculated masses (19) were as follows: A-Ser, 19,865;
A-crystallin, 19,952; A + PO4, 20,032; A + Ser + GSH, 20,170; A + GSH, 20257; A + GSH + PO4, 20, 337;
A + Ser + 2 GSH, 20,475; A + 2 GSH, 20,562; A + 2 GSH + PO4, 20,642.
[View Larger Version of this Image (18K GIF file)]
Loss of Chaperone-like Function of -Crystallin by Mixed
Disulfide Formation and Restoration by GR
The target protein for
the chaperone assay was calf L-crystallin.
Characteristically, L-crystallin aggregates at elevated temperatures. The addition of -crystallin either prevented or decreased the heat-induced aggregation of L-crystallin,
which was measured by light scattering at 360 nm. Short term
experiments were done with an : ratio of 1:10. The ratio of to determines the degree of protection against heat-induced
aggregation. After incubation with 25 mM GSSG,
-crystallin showed a diminished ability to prevent the heat-induced
aggregation of L-crystallin (Fig. 3). Correlation of the decrease in
chaperone activity with the formation of mixed disulfides indicated
that protein mixed disulfides contributed to the loss of -crystallin
chaperone-like function (see Table I). To confirm that the formation of
protein-glutathione mixed disulfides was indeed the cause of this
decrease in chaperone function, GR was added in the presence of 2 mM NADPH to reduce the mixed disulfides. The chaperone
assay resulted in 40% reversal of chaperone-like activity in the calf
L-crystallin (Fig. 3). Similar experiments were
conducted with L-crystallin fractions from young human
lenses incubated with GSSG. The chaperone assay showed a 54% decrease
of the chaperone-like function. Then, with the addition of GR, a 33%
recovery of its function was shown (Fig. 4).
Fig. 3.
Effect of protein-glutathione mixed
disulfides formed in vitro on the molecular chaperone-like
activity of calf L-crystallin. Heat denaturation of
L-crystallin fraction (400 µg) with calf L-crystallin (40 µg) fraction was assayed at 360 nm
for 50 min at 55 °C in a total volume of 1 ml of phosphate buffer,
pH 7.0. Heat denaturation assays were performed with the following:
L alone; control L + L;
L + GSSG + L; L + GSSG (+ GR postincubated) + L.
[View Larger Version of this Image (21K GIF file)]
Fig. 4.
Effect of in vitro formed
glutathione mixed disulfides on the chaperone function of human
-crystallin. Heat denaturation of calf
L-crystallin with young human -crystallin before
(control) and after treatment with GSSG (25 mM)
and GSSG + GR (GR postincubated).
[View Larger Version of this Image (21K GIF file)]
DISCUSSION
-Crystallin is one of the most thermostable proteins in the
lens. It has been shown to protect against heat-induced denaturation and aggregation of many proteins (14, 15) thus acting as a chaperone by
interacting only with denatured nonaggregated crystallins. -Crystallin differs from true chaperones in that it binds to unfolded proteins in a chaperone-like manner preventing aggregation but
does not release its target protein as true chaperones do (33, 34).
Nevertheless, this chaperone-like activity seems indispensable in
maintaining lens transparency and possibly as a mammalian shock protein
in other disorders (6-8). We have attempted to answer whether aging
affects this chaperone function and the underlying cause of it in human
lenses. Some of the causes of this chaperone malfunction are believed
to be posttranslational modifications of -crystallin by oxidation,
glycation, and mixed disulfide formation (28). In this report, we have
shown that the formation of glutathione mixed disulfides is a major
cause of decreased molecular chaperone-like function of -crystallin due to aging. This decrease in chaperone function can in turn affect
the stability of other crystallins and the state of transparency of the
whole lens causing lens opacification.
Lou et al. (23) have reported two or more species of mixed
disulfides in the human lens. The two major species of thiols bound to
proteins are glutathione (PSSG) and cysteine (PSSC). The ratio of PSSG
to PSSC in human is 4:1; PSSC in human lenses appears to be
concentrated in the nuclear region and the water-insoluble fraction
(27). In the present study however, we did not detect PSSC, perhaps
because we have used only the -crystallin from the soluble fraction.
Therefore, the focus of the present work is on protein-glutathione
mixed disulfides.
Depletion of reduced GSH in the lens is associated with the normal
aging process. Depletion of GSH and a concomitant increase of
protein-thiol mixed disulfides during aging have been reported earlier
(23, 27). In vitro induction of mixed disulfide formation in
young human and calf -crystallin via incubation with GSSG, showed a
direct effect of mixed disulfides on chaperone activity (Figs. 3 and
4). Restoration of chaperone activity, as a result of mixed disulfide
reduction by GR also supports this conclusion. These results suggest
that PSSG formation is one of the major causes of declining chaperone
activity in aging lenses. Wang and Spector (35) have shown that
-crystallin can protect oxidation of thiols in -crystallin and
that 70% oxidation of -crystallin thiols with
H2O2 decreased only 20% of chaperone activity
as compared with the native -crystallin. We found a 40% decrease in
the chaperone activity in calf L-crystallin and a 54%
decrease in human L-crystallin after the treatment with
GSSG. Calf A-crystallin has only one cysteine (Cys-131) and the
human A-crystallin contains two cysteines (Cys-131 and Cys-142).
Both cysteines in human lenses formed mixed disulfides, as shown by
mass spectrometric analysis (Fig. 2). Therefore, human
L-crystallin showed a higher level of modification (Table I) and decrease in chaperone activity than calf
L-crystallin. Takemoto (36) has shown oxidation of
Cys-131 and Cys-142 of A-crystallin forming intramolecular
disulfides during human cataract development. Miesbauer et
al. (19) showed the presence of disulfides in the water-soluble
fraction of -crystallin from young lenses. Lund et al.
(22) on the other hand showed all cysteines forming disulfide bonds in
the water-insoluble fraction of -crystallin. Mixed disulfide
formation in human -crystallin could be the precursor for such
disulfide formation. However, the level of -crystallin-bound PSSG in
the old human lenses is still unknown. Our preliminary data indicated
that significant individual variations can be expected because values
of 0.097 mol and 0.022 mol of PSSG/mol of 20-kDa protein were observed
in two different L-crystallin preparations from senile
lenses (a large number of human lenses are under study). Variations in
PSSG levels will not be a surprising observation (24) because of the
varying degrees of oxidative stress senile lenses are subjected to. In
addition, levels of PSSG will be influenced by the presence of
cataracts (24).
The mechanism of the loss in chaperone activity due to mixed disulfide
formation is not clear. One explanation is that the modification of the
abovementioned cysteines causes conformational changes at the binding
site on A-crystallin. It should be emphasized here that the B
subunit is not expected to be modified, and the conformational changes
in the -crystallin oligomer are triggered by modification of one or
two sites on A-crystallin. Takemoto and associates (17) have
concluded by immunological localization of denatured -crystallin
binding that the binding site on -crystallin is localized in the
central region of the oligomeric -crystallin. However, it is not
certain whether the cysteine residues under study are a part of this
region, although it is generally believed that the C-terminal domain of
A polypeptide is an integral part of this central region.
One important outcome of this study is the possibility of reversing the
age-dependent decline in the -crystallin chaperone activity. Young human and calf L-crystallins that formed
mixed disulfides were further incubated with GR in the presence of
NADPH to reduce the mixed disulfides. Reduction of the preformed PSSG led to significant improvement in the chaperone activity. This investigation provides insight into the role of protein-mixed disulfides in chaperone function. Controlling the formation of PSSG by
activating the redox system may be important in protecting the
-crystallin, thus delaying or preventing cataractogenesis.
FOOTNOTES
*
This work was supported by Research Grants EY11352 and
EY07394 (to E. C. A.) and EY07609 (to J. B. S.) from the National
Eye Institute.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Biochemistry and Molecular Biology, Medical College of Georgia,
1120 15th St., Augusta, GA 30912-2100. Tel.: 706-721-9526; Fax:
706-721-6300.
1
The abbreviations used are: GSH, glutathione;
PSSG, protein-glutathione mixed disulfides; GSSG, oxidized glutathione,
PSSC, protein-cysteine mixed disulfides; GR, glutathione reductase; HPLC, high pressure liquid chromatography; PITC,
phenylisothiocyanate.
REFERENCES
-
Bhat, S. P., and Nagineni, C. N.
(1989)
Biochem. Biophys. Res. Commun.
158,
319-325
[CrossRef][Medline]
[Order article via Infotrieve]
-
Iwaki, T., Kume-Iwaki, A., Liem, R. K. H, and Goldman, J. E.
(1989)
Cell
57,
71-78
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dubin, R. A., Wawrousek, E. F., and Piatigorsky, J.
(1989)
Mol. Cell. Biol.
9,
1083-1091
[Abstract/Free Full Text]
-
Kato, K., Shinohara, H., Kurobe, N., Goto, S., Inaguma, Y., and Ohshima, K.
(1991)
Biochem. Biophys. Acta.
1080,
173-180
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bhat, S. P., Horwitz, J., Srinivasan, A., and Ding, L.
(1991)
Eur. J. Biochem.
202,
775-781
[Medline]
[Order article via Infotrieve]
-
Srinivasan, A. N., Nagineni, C. N., and Bhat, S. P.
(1992)
J. Biol. Chem.
267,
23337-23341
[Abstract/Free Full Text]
-
van Noort, J. M., van Sechel, A. C., Bajramovic, J. J., El Ouagmiri, M., Polman, C. H., Lassmann, H., and Ravid, R.
(1995)
Nature
375,
798-801
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lowe, J., Landon, M., Pike, I., Spendlove, I., McDermott, H., and Mayer, R. J.
(1990)
Lancet
336,
515-516
[Medline]
[Order article via Infotrieve]
-
Klemenz, R., Frohli, E., Steiger, R. H., Schafer, R., and Aoyama, A.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
3652-3656
[Abstract/Free Full Text]
-
Dasgupta, S., Hohman, T. C., and Carper, D.
(1992)
Exp. Eye Res.
54,
461-470
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ingolia, T. D., and Craig, E. A.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
2360-2364
[Abstract/Free Full Text]
-
Hickey, E., Brandon, S. E., Potter, R., Stein, G., Stein, J., and Weber, L. A.
(1986)
Nucleic Acids Res.
14,
4127-4145
[Abstract/Free Full Text]
-
Arrigo, A. P., Suhan, J. P., and Welch, W. J.
(1988)
Mol. Cell. Biol.
8,
5059-5071
[Abstract/Free Full Text]
-
Horwitz, J.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
10449-10453
[Abstract/Free Full Text]
-
Horwitz, J., Emmons, T., and Takemoto, L.
(1992)
Curr. Eye Res.
11,
817-822
[Medline]
[Order article via Infotrieve]
-
Rao, P. V., Horwitz, J., and Zigler, J. S., Jr.
(1993)
Biochem. Biophys. Res. Comm.
190,
786-793
[CrossRef][Medline]
[Order article via Infotrieve]
-
Boyle, D., Gopalakrishnan, S., and Takemoto, L.
(1993)
Biochem. Biophys. Res. Comm.
192,
1147-1154
[CrossRef][Medline]
[Order article via Infotrieve]
-
Groenen, P. J. T. A., van Dongen, M. J., Voorter, C. E. M., Bloemendal, H., and de Jong, W. W.
(1993)
FEBS Lett.
322,
69-72
[CrossRef][Medline]
[Order article via Infotrieve]
-
Miesbauer, L. R., Zhou, X., Yang, Z., Yang, Z., Sun, Y., Smith, D. L., and Smith, J. B.
(1994)
J. Biol. Chem.
269,
12494-12502
[Abstract/Free Full Text]
-
Fujii, N., Ishibashi, Y., Satoh, K., Fujino, M., and Harada, K.
(1994)
Biochim. Biophys. Acta
1204,
157-163
[CrossRef][Medline]
[Order article via Infotrieve]
-
Takemoto, L., Horwitz, J., and Emmons, T.
(1992)
Curr. Eye Res.
11,
651-655
[Medline]
[Order article via Infotrieve]
-
Lund, A. L., Smith, J. B., and Smith, D. L.
(1996)
Exp. Eye Res.
63,
661-672
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lou, M. F., Dickerson, J. E., Jr., and Garadi, R.
(1990)
Exp. Eye Res.
50,
819-826
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dickerson, J. E., Jr., and Lou, M. F.
(1993)
Biochim. Biophys. Acta.
1157,
141-146
[Medline]
[Order article via Infotrieve]
-
Swamy, M. S., Abraham, A., and Abraham, E. C.
(1992)
Exp. Eye Res.
54,
337-345
[Medline]
[Order article via Infotrieve]
-
Sippel, T. O.
(1966)
Invest. Ophthalmol.
5,
568-575
[Abstract/Free Full Text]
-
Lou, M. F., and Dickerson, J. E., Jr.
(1992)
Exp. Eye Res.
55,
889-896
[CrossRef][Medline]
[Order article via Infotrieve]
-
Cherian, M., and Abraham, E. C.
(1995)
Biochem. Biophys. Res. Comm.
208,
675-679
[CrossRef][Medline]
[Order article via Infotrieve]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kumari, K., Khanna, P., Ansari, N. H., and Srivastava, S. K.
(1994)
Anal. Biochem.
220,
374-376
[Medline]
[Order article via Infotrieve]
-
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
[CrossRef][Medline]
[Order article via Infotrieve]
-
Delcour, J., and Papaconstantinou, J.
(1974)
Biochem. Biophys. Res. Commun.
57,
134-141
[CrossRef][Medline]
[Order article via Infotrieve]
-
Roa, P. V., Huang, Q., Horwitz, J., and Zigler, J. S., Jr.
(1995)
Biochim. Biophys. Acta.
1245,
439-447
[Medline]
[Order article via Infotrieve]
-
Carver, J. A., Guerreiro, N., Nicholls, K. A., and Truscott, R. J.
(1995)
Biochim. Biophys. Acta.
1252,
251-260
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wang, K., and Spector, A.
(1995)
Invest. Ophthalmol. Visual Sci.
36,
311-321
[Abstract/Free Full Text]
-
Takemoto, L. J.
(1996)
Biochem. Biophys. Res. Comm.
223,
216-220
[Medline]
[Order article via Infotrieve]
Volume 272, Number 46,
Issue of November 14, 1997
pp. 29099-29103
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Pandey, S. Chakraborty, A. Datta, and N. Chakraborty
Proteomics Approach to Identify Dehydration Responsive Nuclear Proteins from Chickpea (Cicer arietinum L.)
Mol. Cell. Proteomics,
January 1, 2008;
7(1):
88 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Nordgaard, K. M. Berg, R. J. Kapphahn, C. Reilly, X. Feng, T. W. Olsen, and D. A. Ferrington
Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration.
Invest. Ophthalmol. Vis. Sci.,
March 1, 2006;
47(3):
815 - 822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Thampi, A. Hassan, J. B. Smith, and E. C. Abraham
Enhanced C-Terminal Truncation of {alpha}A- and {alpha}B-Crystallins in Diabetic Lenses
Invest. Ophthalmol. Vis. Sci.,
October 1, 2002;
43(10):
3265 - 3272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. MacCoss, W. H. McDonald, A. Saraf, R. Sadygov, J. M. Clark, J. J. Tasto, K. L. Gould, D. Wolters, M. Washburn, A. Weiss, et al.
Shotgun identification of protein modifications from protein complexes and lens tissue
PNAS,
June 11, 2002;
99(12):
7900 - 7905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Perng, P. J. Muchowski, P. van den IJssel, G. J. S. Wu, A. M. Hutcheson, J. I. Clark, and R. A. Quinlan
The Cardiomyopathy and Lens Cataract Mutation in alpha B-crystallin Alters Its Protein Structure, Chaperone Activity, and Interaction with Intermediate Filaments in Vitro
J. Biol. Chem.,
November 19, 1999;
274(47):
33235 - 33243.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|